Drug Research
Data-Driven Discoveries Get Powered By Lab Connectivity
Technology has gone on to change almost every aspect when it comes to the daily lives and has swiftly redefined the way one manages science. The digital disruption, which has been brought about by a massive influx of innovative...
Drug Research
Most Studied Diseases List Has Breast Cancer At The Top
Oncology research has gone on to attain priority status and has apparently been flush with pharma research dollars for years. The fact is that drug development companies went on to raise $7 billion in 2020 because of the disease’s...
Drug Research
Cresset Aims to Optimise Drug Discovery with Latest Drug Design Platform Release
Cresset, a provider of integrated in silico solutions for drug discovery, has released the latest version of its Flare drug discovery platform, which aims to improve ligand and structure-based drug design and the lead optimization process in early drug...
Drug Research
Single-Use Systems To Push Growth of E&L Testing Market
The worldwide extractable and leachable- E&L testing services market is all set to value $2.57 million by 2030, as per the latest report by ResearchAndMarkets. Between 2023 and 2030, this goes on to represent a CAGR of 15.13%, as...
Drug Research
GDMC Secures US$21 Million Growth Capital Funding to Expand Global Genetic Medicines Design and Manufacturing Operations
Genetic Design and Manufacturing Corporation (GDMC), a design and manufacturing organization that focuses on next generation advanced genetic therapies, today announced a Series A funding of US$21 million. The funding round is led by Celadon Partners, an Asia private...
Drug Research
Whole Genome Sequencing in Cancer Care: Strong Proof Seen
Blending the routine clinical data along with the whole genome sequence- WSG data at scale goes on to support clinicians when it comes to the delivery of precision cancer care, as per new landmark research.
Published in the journal Nature...
Drug Research
Abzena launches AbZelect platforms for improving cell line development efficiency on the pathway to IND
Abzena, the leading end-to-end CDMO for biologics and bioconjugates, has launched AbZelect™ and AbZelectPRO™ cell line development (CLD) platforms for accelerating the generation of production cell lines for manufacture of antibodies and recombinant proteins. The platforms will enable Abzena...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read